Market closed
Renovaro/RENB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Renovaro
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Ticker
RENB
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
12
Website
Renovaro Metrics
BasicAdvanced
$72M
Market cap
-
P/E ratio
-$0.73
EPS
0.60
Beta
-
Dividend rate
Price and volume
Market cap
$72M
Beta
0.6
52-week high
$5.25
52-week low
$0.42
Average daily volume
484K
Financial strength
Current ratio
0.058
Quick ratio
0.015
Long term debt to equity
0.722
Total debt to equity
6.765
Interest coverage (TTM)
-24.03%
Management effectiveness
Return on assets (TTM)
-12.02%
Return on equity (TTM)
-87.88%
Valuation
Price to book
0.43
Price to tangible book (TTM)
-1.78
Price to free cash flow (TTM)
-3.331
Growth
Earnings per share change (TTM)
-38.77%
3-year earnings per share growth (CAGR)
60.42%
Renovaro Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Renovaro News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Renovaro stock?
Renovaro (RENB) has a market cap of $72M as of October 08, 2024.
What is the P/E ratio for Renovaro stock?
The price to earnings (P/E) ratio for Renovaro (RENB) stock is 0 as of October 08, 2024.
Does Renovaro stock pay dividends?
No, Renovaro (RENB) stock does not pay dividends to its shareholders as of October 08, 2024.
When is the next Renovaro dividend payment date?
Renovaro (RENB) stock does not pay dividends to its shareholders.
What is the beta indicator for Renovaro?
Renovaro (RENB) has a beta rating of 0.6. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.